Union Health Secretary says “Various countries have explored various approaches to financial assistance for vaccine development. They include advance market commitments; providing financial help to vaccine manufacturers in terms of conducting R&D, this financial support may come from financial institutions.
“In India, through Department of Biotechnology, direct financial assistance is being given already to the designated vaccine manufacturers to assist in R&D and pre-clinical trials, may get extended to clinical trials. Other options are also on the table, which may be explored. At the present moment, we will not hazard a guess on the total outgo on the vaccines. Sufficient financial resources are, however, available with the government to procure the vaccine.”
“A sub-group under the National Committee of Experts on Vaccine Administration has already mapped the cold chain facilities already existing for immunisation programmes of the government. It has also made a projection of the additional requirement. The sub-group is now mapping the private sector facilities, with minor modifications, they can be used for the purpose,” says Mr. Bhushan. –The Hindu